ArticleAnatolian journal of cardiology2021

The impact of discontinuation of sacubitril-valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction.

Osama A Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.